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DObjective: Infants undergoing cardiac surgery often have postoperative bleeding contributing to the occurrence
of adverse events. A quantitative evaluation of postoperative bleeding has not been well described.
Methods: We identified 1071 infants who had undergone cardiopulmonary bypass from August 1, 2008 to
December 31, 2011. The volume of postoperative bleeding and its effect on mortality were reviewed.
Results: Postoperative bleeding during the first 12 hours postoperatively was stratified by quartiles. Bleeding
was significantly associated with increased mortality (odds ratio [OR], 1.15; 95% confidence interval [CI]
1.10-1.21; P<.001). Other risk factors significantly associated with mortality included greater Risk Adjustment
for Congenital Heart Surgery score (OR, 1.5; 95% CI, 1.22-1.85; P<.001), single ventricle anatomy (OR, 3.09;
95% CI, 1.68-5.67; P<.001), younger age (OR, 0.99; 95% CI, 0.98-0.99; P<.001), and longer perfusion time
(OR, 1.01; 95% CI, 1.01-1.02; P<.001). Subjects with greater bleeding volumes experienced a longer postop-
erative mechanical ventilation and intensive care unit stay. The overall hospital mortality was 4.1%. On multi-
variate analysis, adjusting for age, single ventricle anatomy, Risk Adjustment for Congenital Heart Surgery
score, and perfusion time, an increasing bleeding volumewas independently associated with increasedmortality.
Packed red blood cell transfusion was independently associated with an increased duration of mechanical venti-
lation (P ¼ .01) and intensive care unit length of stay (P ¼ .003).
Conclusions: Early postoperative hemorrhage was independently associated with an increased mortality in
infants after cardiac surgery. The longer interval from surgery to death suggests that other factors, aside from
the bleeding itself, including the transfusion volume, might contribute to mortality. Initiatives to limit postop-
erative bleeding and to critically appraise packed red blood cell transfusion practices are warranted. (J Thorac
Cardiovasc Surg 2014;148:631-6)Supplemental material is available online.
Infants who undergo cardiac surgery within the first year of
life often experience significant postoperative bleeding af-
ter admission to the intensive care unit (ICU).1 In addition
to the extensive suture lines, increased hemodilution, acti-
vation of the coagulation system, and hemostatic derange-
ments after cardiopulmonary bypass (CPB) increase the
risk of postoperative bleeding.1-4 Inherent deficiencies in
antithrombin and other coagulation proteins can also
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The Journal of Thoracic and CaExcessive postoperative bleeding will often be treated
with blood products, including packed red blood cells
(PRBCs), fresh frozen plasma, platelets, and thawed cryo-
precipitate. In cases of severe bleeding, activated factor
VII will often be administered to achieve adequate hemo-
stasis.7 Laboratory tests, including the thromboelastogram,
have allowed for specific targeting of deficient areas of the
coagulation system during ongoing bleeding.8 When factor
and product replacement have failed to achieve hemostasis,
surgical exploration will usually be undertaken.
Excessive postoperative bleeding requires replacement
with blood transfusions. Although safe during administra-
tion, blood transfusions carry several risks that can affect
morbidity and mortality after cardiac surgery. Adult data
have demonstrated increased mortality risk in association
with PRBC transfusion after coronary artery bypass grafting9
and a significant effect on long- and short-term survival after
all types of adult heart surgery.10 Pediatric data have demon-
strated an increased duration of mechanical ventilation and
ICU length of stay in relation to blood transfusions, with no
demonstrable survival benefit for aggressive transfusion stra-
tegies comparedwith conservative transfusion strategies.11-17
The primary goal of the present study was to examine the
relationship of early postoperative bleeding in infants withrdiovascular Surgery c Volume 148, Number 2 631
Abbreviations and Acronyms
CPB ¼ cardiopulmonary bypass
ICU ¼ intensive care unit
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RACHS ¼ Risk Adjustment for Congenital Heart
Surgery
Congenital Heart Disease Wolf et al
C
H
Dsurgical mortality and adverse events. We hypothesized that
increasing amounts of postoperative bleeding would be
associated with an increased mortality risk and adverse
events, including a prolonged duration of mechanical venti-
lation and ICU length of stay. In particular, we focused on a
quantitative evaluation of early postoperative bleeding after
infant cardiac surgery and its effect on mortality.METHODS
Study Design
The Children’s Healthcare of Atlanta institutional review board
approved the present study. Data were collected from the individual med-
ical records and our institutional surgical database. All infants<1 year of
age who had undergone cardiac surgery with CPB from August 1, 2008
through December 31, 2011 were included in the present analysis. Early
postoperative bleeding was defined as bleeding that occurred within the
first 12 hours after ICU admission. All patients included in the analysis
were treated in the cardiac ICU postoperatively.
In addition to the volume of postoperative bleeding, the data collected
included age, weight, height, cardiac anatomy, presence of chromosomal
anomaly, Risk Adjustment for Congenital Heart Surgery (RACHS) score,
perfusion time in the operating room, blood products received in the oper-
ating room, blood products received in the ICU, mechanical ventilation
duration, length of ICU stay, in-hospital mortality, postoperative cardiac ar-
rest, postoperative infection confirmed by positive wound culture or blood
culture findings, delayed sternal closure, need for surgical re-exploration,
need for mechanical circulatory support, and need for continuous renal
replacement therapy.
Each operative admission was treated separately. In patients who under-
went>1 operation during an admission, the primary operation for which
they had been admitted to the hospital was chosen for analysis. As such,
the patients who underwent a stage I Norwood operation as a newborn
and a subsequent cavopulmonary anastomosis at 4 months of age were
included in the analysis as 2 unique encounters.
The CPB anticoagulation protocol at the Children’s Healthcare of
Atlanta during the entire study period consisted of a single bolus dose of
500 U/kg of unfractionated heparin immediately before the initiation of
CPB. Monitoring was achieved with activated clotting times, with a goal
of>500 seconds. Repeat doses of heparin (100 U/kg) were given to main-
tain the activated clotting time>500 seconds throughout the duration of
CPB. Aminocaproic acid (Amicar; Clover Pharmaceuticals, Marietta,
Ga) was routinely administered to infants undergoing repeat sternotomy.
After CPB, a dose of protamine (5 mg/kg) was administered to reverse anti-
coagulation. Ongoing bleeding in the operating room was treated with
platelets, thawed cryoprecipitate, and fresh frozen plasma. In cases of se-
vere bleeding for which a surgical cause could not be identified, activated
factor VII was used.
The vast majority of patients underwent bicaval cannulation and moder-
ate hypothermia (28-32C), except for neonates undergoing aortic arch
reconstruction or a first stage Norwood procedure, for whom hypothermia
to 18Cwas typically used with regional cerebral perfusion. The use of pro-
found hypothermic circulatory arrest for>2 or 3 minutes was rare. The632 The Journal of Thoracic and Cardiovascular Surghematocrit was maintained at>28%, often with the use of hemofiltration
during CPB. Modified venovenous ultrafiltration at the termination of
CPB, particularly in neonates was commonly (but not universally) used,
according to surgeon preference. The cell saver was also available for virtu-
ally all patients and was generally preferred over PRBCs both in the oper-
ating room and in the ICU.
Patients who continued to have significant bleeding on admission to
the cardiac ICU were treated further with multiple blood products,
including fresh frozen plasma, platelets, thawed cryoprecipitate, and
PRBCs. In severe cases, repeat dosing of activated factor VII was used.
The coagulation tests used included the prothrombin time, activated par-
tial thromboplastin time, international normalized ratio, and anti-Xa
assay. Thromboelastography and platelet mapping were also used more
recently to help target specific areas of the coagulation system, if the
bleeding was difficult to control. When the bleeding could not be
controlled medically, or if signs or symptoms of pericardial tamponade
developed, surgical exploration was undertaken to identify a specific
source of bleeding.
The primary outcome of the present study was in-hospital mortality.
Secondary outcomes were the mechanical ventilation duration and length
of ICU stay.
Statistical Analysis
Statistical analysis was performed using STATA, version 12.0, software
(StataCorp LP, College Station, Tex) and Statistical Analysis Software,
version 9.3 (SAS Institute Inc, Cary, NC). Univariate analysis was per-
formed using Student’s t test or analysis of variance for continuous data
and Fisher’s exact test or c2 for categorical data. Multivariate logistic
and linear regression analysis was undertaken to adjust for covariates. To
predict the effect of postoperative bleeding on mortality risk, all variables
with P<.1 on univariate analysis were entered into a multivariate logistic
regression analysis.RESULTS
A total of 1071 infants<1 year of age underwent cardiac
surgery with CPB during the study period. To quantify the
bleeding amounts, the patients were stratified by quartile
according to the quantity of bleeding during the first 12
postoperative hours: 0 to 1.19, 1.20 to 2.00, 2.01 to 4.19,
and4.20 mL/kg/h. The patient characteristics are summa-
rized in Table 1.
The patients in the higher quartiles were younger,
weighed less, and had greater RACHS scores and longer
perfusion times (P<.001). Patients in the highest quartile
had a median age of 8 days (range, 0-346) compared with
a median age of 103 to 158 days in the 3 lower quartiles
(P<.001). The median weight in the highest quartile was
3.4 kg (range, 2.0-8.7) compared with a median weight of
4.4 to 5.8 kg in the 3 lower quartiles (P<.001). The median
RACHS score in the 2 highest quartiles was 3 compared
with a score of 2 in the 2 lower quartiles (P<.001). The
perfusion time also increased with increasing quartile.
The median perfusion time in the lowest quartile was 76
minutes (range, 18-211), increasing to 139 minutes in the
highest quartile (range, 31-361; P<.001).
Single ventricle anatomy was present in 22% to 30% of
the patients across the quartiles, with a trend toward statis-
tical significance (P ¼ .08). Chromosomal anomalies were
present in 11% to 17%, and heterotaxy syndrome rangedery c August 2014
TABLE 1. Patient characteristics
Characteristic
Bleeding quartile (mL/kg/h)
P value0-1.18 1.19-2.00 2.01-4.19 4.2
Patients (n) 265 268 268 270 —
Age (d) 152 (1-363) 138 (1-356) 103 (1-336) 8 (0-346) .001
Weight (kg) 5.8 (2.4-10.3) 5.5 (2.0-10.8) 4.4 (2.0-9.8) 3.4 (2.0-8.7) .001
RACHS 2 (1-6) 2 (1-6) 3 (2-6) 3 (1-6) .001
Single ventricle 74 (28) 59 (22) 60 (22) 81 (30) .08
Chromosomal anomaly 46 (17) 30 (11) 34 (13) 42 (16) .17
Heterotaxy 12 (5) 11 (4.1) 5 (1.9) 12 (4) .31
Data presented as median (range) or n (%). RACHS, Risk adjustment for congenital heart surgery.
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Dfrom 1.9% to 5%, with no significant difference across the
quartiles. The surgical details and outcomes are summa-
rized in Table 2.
Mortality increased across the quartiles, with 10% mor-
tality in the highest bleeding quartile, 4.5% in the third,
1.1% in the second, and 0.4% in the lowest quartile
(P< .001). The overall hospital mortality for all patients
analyzed was 4.1%. The interval from surgery to death
was similar in the second and fourth quartiles (median, 16
and 14 days, respectively) and longest in the third quartile
(median, 21 days). One death occurred in the lowest quartile
1 day after surgery (Figure 1).
The PRBC volume transfused increased across the quar-
tiles, with patients in the highest quartile receiving a median
of 8.8 mL/kg (range, 0-395) of transfused blood during the
first 12 postoperative hours. The median PRBC volume
transfused was 0 for the 3 lower quartiles, although the
mean volume increased from 3.0 mL/kg within 12 hours
in the lowest quartile to 6.7 mL/kg within 12 hours in the
third quartile. Of the 1071 patients in our cohort, 644 did
not receive any PRBC transfusions after surgery. The cell




Patients (n) 265 268
Postoperative ECMO 1 (0.4) 4 (1.5)
Postoperative cardiac arrest 5 (1.9) 6 (2.2)
Postoperative infection 6 (2.3) 5 (1.9)
Open sternum 6 (2.3) 11 (4.1)
Postoperative CVVH 1 (0.4) 0 (0)
Reoperation for bleeding 2 (0.8) 3 (1.1)
Perfusion time (min) 76 (18-211) 81 (18-31
PRBC (mL/kg/12 h) 0 (0-48) 0 (0-41)
Ventilator duration (h) 22 (0-2233) 23 (0-324
ICU length of stay (h) 51 (12-2680) 51 (18-15
Death 1 (0.4) 3 (1.1)
Interval from surgery to death (d) 1 16 (7-113
Data presented as n (%) or median (range). ECMO, Extracorporeal membrane oxygenation
intensive care unit.
The Journal of Thoracic and CaPRBCs. The mean volume transfused in the highest quartile
was 22 mL/kg within 12 hours.
The duration of mechanical ventilation increased across
the quartiles, with the lowest 3 quartiles having a median
duration of 22 to 42 hours and the highest quartile, a median
duration of 119 hours (range, 0-3632; P<.001). The ICU
length of stay was similar, with a median range of 51 to
93 hours in the 3 lowest quartiles and 180 hours (range,
22-2931) in the highest quartile (P<.001; Figure E1).
Other factors that increased across quartiles included
mechanical circulatory support, postoperative cardiac
arrest, delayed sternal closure, postoperative renal replace-
ment therapy (continuous venovenous hemofiltration), and
reoperation to control bleeding. The infection rates did
not differ significantly across the quartiles.
Using multivariate logistic regression analysis, after
adjustment for age, weight, single ventricle anatomy,
RACHS score, and perfusion time, an increasing bleeding
quartile was independently associated with mortality risk,
with an odds ratio of 1.15 (95% confidence interval 1.07-
1.22; P<.001). Although PRBC transfusion emerged as a
significant risk factor for mortality on univariate analysisding quartile (mL/kg/h)
P value0 2.01-4.19 4.2
268 270 —
9 (3.4) 25 (9.3) .001
6 (2.2) 32 (12) .001
13 (4.9) 16 (5.9) .03
43 (16) 103 (38) .001
3 (1.1) 14 (5.2) .001
1 (0.4) 16 (5.9) .001
5) 103 (24-307) 139 (31-361) .001
0 (0-48) 8.8 (0-395) .001
7) 42 (0-3248) 119 (0-3632) .001
97) 93 (22-2038) 180 (22-2931) .001
12 (4.5) 27 (10) .001
) 21 (3-100) 14 (0-201) .001
; CVVH, continuous venovenous hemofiltration; PRBC, packed red blood cells; ICU,
rdiovascular Surgery c Volume 148, Number 2 633
FIGURE 1. Hospital mortality rates stratified by quartile.
TABLE 4. Multivariate mortality risk adjustment
Risk factor OR 95% CI P value
Age 0.99 0.98-0.99 .002
Single ventricle 2.09 0.90-4.84 .0853
RACHS 1.06 0.80-1.41 .6901
Perfusion time 1.00 0.99-1.01 .4459
Bleeding (mL/kg/h) 1.15 1.07-1.22 <.001
PRBC (yes vs no) 1.58 0.71-3.53 .2669
PRBC (per 100 mL
transfused)
0.99 0.73-1.32 .9187
OR, Odds ratio; CI, confidence interval; RACHS, Risk Adjustment for Congenital
Heart Surgery; PRBC, packed red blood cell.
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P< .001), it did not reach statistical significance in our
multivariate model (odds ratio, 1.58; 95% confidence inter-
val, 0.71-3.53; P ¼ .3). The univariate and multivariate
analysis results are summarized in Tables 3 and 4.
The effect of postoperative bleeding and PRBC transfu-
sion on the duration of mechanical ventilation and ICU
length of stay was also assessed using multivariate linear
regression analysis. Controlling for age, RACHS score,
perfusion time, and single ventricle anatomy, the effect of
bleeding volume and PRBC transfusion was assessed.
Patients with a greater bleeding volume had a longer dura-
tion of mechanical ventilation (P<.001) and ICU length of
stay (P ¼ .005). Patients who received PRBC transfusions
also had a longer mechanical ventilation duration
(P ¼ .01) and ICU length of stay (P ¼ .003).
DISCUSSION
This is the first study to our knowledge to quantitatively
evaluate the effect of postoperative bleeding on hospital
mortality risk after infant cardiac surgery. Although previ-
ous studies have examined the risk factors for increased
postoperative blood loss,1,4 the effect on increased
mortality risk was not described. In addition, the adverse
effects of blood transfusions, including a longer duration
of mechanical ventilation and ICU stay, have been well
described in the pediatric data11,12,18; however, the effect
on mortality risk has not been.TABLE 3. Univariate mortality risk model
Risk factor OR 95% CI P value
Age 0.99 0.98-0.99 <.001
Single ventricle 3.09 1.68-5.67 <.001
RACHS 1.5 1.22-1.85 <.001
Perfusion time 1.01 1.01-1.02 <.001
Bleeding (mL/kg/h) 1.15 1.10-1.21 <.001
PRBCs (yes vs no) 2.25 1.22-4.16 <.001
PRBC (per 100 mL
transfused)
1.33 1.14-1.55 <.001
OR, Odds ratio; CI, confidence interval; RACHS, Risk Adjustment for Congenital
Heart Surgery; PRBC, packed red blood cell.
634 The Journal of Thoracic and Cardiovascular SurgWe identified several risk factors for increased blood loss
in the postoperative period. In agreementwith the findings of
Williams and colleagues,1,4 younger age and lower weight
both increased the risk and quantity of postoperative
bleeding. A greater RACHS score and longer perfusion
time were also associated with increased mortality risk
and quantity of bleeding. The bleeding risk was not
affected by the presence of a chromosomal anomaly, or
heterotaxy syndrome, although single ventricle anatomy
was associated with increased mortality risk on univariate
analysis.
The mortality risk was significantly affected by an
increased quantity of bleeding, with the risk of death more
than doubling with each increased quartile. Aside from 1
patient in the lowest quartile who died on postoperative
day 1, the median interval from surgery to death ranged
from 16 to 24 days in the 3 highest quartiles. Several factors
could have influenced these intervals. Blood transfusions are
known to cause inflammation, especially in the pulmonary
system, when given in large quantities, known as
transfusion-associated lung injury.19,20 Infants who
experience significant postoperative hemorrhage tended to
receive larger quantities of transfused blood products,
increasing their risk of transfusion-associated lung injury.
With increased lung inflammation, the duration of mechani-
cal ventilation and its associated complications, including
increased mortality, increased. Other factors that influenced
the increased mortality risk were the greater incidence of
postoperative cardiac arrest, mechanical circulatory support,
and renal replacement therapy, all of which are independent
risk factors for mortality after infant cardiac surgery.
The duration of mechanical ventilation and ICU length of
stay were both independently affected by an increasing vol-
ume of postoperative bleeding. This remained statistically
significant when controlling for other significant confound-
ing variables. We attributed this to several factors. In addi-
tion to those mentioned, the patients with ongoing bleeding
were more likely to return from the operating room with an
open sternum and require subsequent surgical exploration
because of bleeding, both of which increased the duration
of mechanical ventilation and ICU length of stay.ery c August 2014
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quartiles. This was in contrast to the findings of several pre-
vious studies that identified delayed sternal closure, length
of ICU stay, and duration of mechanical ventilation as risk
factors for postoperative infection.21-23 All patients at our
institution were treated with perioperative cefazolin for
the first 48 hours after surgery, and those with an open
sternum were treated with vancomycin and gentamycin
until 24 hours after delayed sternal closure. These
preemptive antibiotics might have lowered the infection
risk across all groups. In addition, the objective of the
present study was to analyze the association of
postoperative bleeding with the clinical outcomes. The
study was not designed to assess the effect of red blood
cell transfusion per se on outcomes.
Blood transfusions are frequently given after infant car-
diac surgery, and their adverse effect on outcomes has
continued to emerge. Although the primary goal of the pre-
sent study was to identify the increased mortality risk asso-
ciated with increasing quantities of postoperative bleeding,
PRBC transfusions were found to increase mortality risk.
Although this effect did not remain onmultivariate analysis,
we raise the concern that the need for increased transfusions
in the setting of significant bleeding plays a role in
increasing mortality risk. Given the retrospective nature
of the present study, it was difficult to differentiate the exact
contributions that early postoperative bleeding and the
resultant blood transfusions had on increased mortality risk.
We found an independent relationship between PRBC
transfusion and an increased mechanical ventilation dura-
tion and ICU length of stay. These findings were in line
with the findings of Salvin and colleagues11 and Kipps
and colleagues.12
From our results, we stress the importance achieving
adequate hemostasis in the operating room before ICU
admission. All the risk factors identified in the present
study occurred postoperatively in the ICU. By meticu-
lously controlling postoperative bleeding in the operating
room, a significant effect could be made on patient mortal-
ity. Although it is self-evident that 1 of the goals of
congenital heart surgery is to minimize bleeding, strategies
to achieve hemostasis must be balanced against the poten-
tial risks. Aggressive strategies to establish hemostasis
could induce a prothrombotic state, leading thrombotic
vessel occlusion. Some centers have advocated the use of
fresh whole blood to minimize inflammation and induce
a more favorable anticoagulation profile. Others have
suggested that the use of aprotinin (currently not available
in the United States) might lessen postoperative
bleeding.14,24-26 In addition, given the independent
association of blood transfusions and mortality, we stress
the importance of weighing the risks and benefits of each
transfused blood product, especially PRBCs, before
administration. Their potential benefits, includingThe Journal of Thoracic and Caincreased oxygen carrying capacity and improved
hemodynamics, have been well described16,18; however,
the adverse effects are an important consideration, even
for patients with ongoing bleeding.27-30
The present study had several important limitations. This
was a single-center, retrospective analysis, and practices
regarding hemostasis and the treatment of ongoing bleeding
differ across institutions. In addition, several confounders
were present that influenced the primary and secondary out-
comes of the present study. Although these were controlled
for in our multivariate analysis, their independent effect
cannot be ignored. Although the independent association
of an increasing quantity of postoperative bleeding and
mortality was convincing, the association of transfusion
was less so. A randomized controlled trial to analyze the in-
dependent effect of blood transfusions after infant cardiac
surgery is necessary to provide definitive guidelines for
their use.CONCLUSIONS
Early postoperative hemorrhage after infant cardiac sur-
gery was independently associated with increased in-
hospital mortality risk, a longer duration of mechanical
ventilation, and an increased ICU length of stay. The longer
interval from surgery to death seems to indicate that several
mechanisms, other than bleeding itself and that might
include factors such as inflammation and transfusion vol-
ume, could contribute to mortality. PRBC transfusions
were also independently associated with an increased dura-
tion of mechanical ventilation and ICU length of stay. Ini-
tiatives to limit postoperative bleeding and critically
appraise PRBC transfusion practices are warranted.
We acknowledge the work of Alexandra Ehrlich, MPH, on the
statistical portion of our report.References
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FIGURE E1. Median ventilator and intensive care unit (ICU) hours strat-
ified by quartile.
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